T-cells in angiotensin-II-induced vascular damage (Nephrology Dialysis Transplantation (2007) DOI: 10.1093/ndt/gfm867);T-cells in angiotensin-II-induced vascular damage

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1107-1108

  Helmut, Geiger ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Hypertension; T cells

Indexed keywords

ANGIOTENSIN II; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; ETANERCEPT; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; OXYGEN; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG MECHANISM; HYPERTENSION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; BLOOD VESSEL; CELLULAR IMMUNITY; DISEASE COURSE; DRUG EFFECT; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION; REVIEW; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CHEMOKINE CCL5; DISEASE PROGRESSION; HUMANS; HYPERTENSION, RENAL; IMMUNITY, CELLULAR; T-LYMPHOCYTES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 42949146630     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn293     Document Type: Erratum

References (13)

1. Geiger H, Fierlbeck W, Mai M et al. Effects of early and late anti-hypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR. Kidney Int 1997; 51: 750-761
2. Mai M, Hilgers KF, Geiger H. Experimental studies on the role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in hypertensive nephrosclerosis. Hypertension 1996; 28: 973-979
3. Muller DN, Shagdarsuren E, Park JK et al. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 2002; 161: 1679-1693
4. Tian N, Jordan S, Rose RA et al. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007; 292: H1018-H1025
5. Rodriguez-Iturbe BY, Quiroz M, Nava L et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002; 282: F191-F201
6. Bataillard A, Freiche JC, Vincent M et al. 1986. Antihypertensive effect of neonatal thymectomy in the genetically hypertensive LH rat. Thymus 1986; 8: 321-330
7. Balsari A, Marolda R, Gambacorti-Passerini C et al. Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. Cancer Immunol Immunother 1986; 21: 148-155
8. Herrera J, Ferrebuz A, Macgregor EG et al. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 2006; 17: S218-S225
9. Parker SB, Wade SS, Prewitt RL. Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression. Hypertension 1998; 32: 452-458
10. Huang M, Hester RL, Coleman TG et al. Development of hypertension in animals with reduced total peripheral resistance. Hypertension 1992; 20: 828-833
11. Li JJ, Fang CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses 2005; 64: 236-240
12. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003; 290: 3000-3002
13. Guzik TJ, Hoch NE, Brown KA et al. Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-2460